1. Adjustment of the area under the concentration curve by terminal rate constant for bioequivalence assessment in a parallel‐group study of lamotrigine. Issue 3 (17th January 2019) Authors: Yang, Jiansong; Ma, Peiming; Bullman, Jonathan; Nicholls, Andrew; Chen, Chao Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 3(2019) Page Start: 563 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The effects of GSK2981710, a medium‐chain triglyceride, on cognitive function in healthy older participants: A randomised, placebo‐controlled study. (23rd May 2019) Authors: O'Neill, Barry V.; Dodds, Chris M.; Miller, Sam R.; Gupta, Ashutosh; Lawrence, Philip; Bullman, Jonathan; Chen, Chao; Dewit, Odile; Kumar, Subramanya; Dustagheer, Mushi; Price, Jeffrey; Shabbir, Shaila; Nathan, Pradeep J. Journal: Human psychopharmacology Issue: Volume 34:Number 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients. Issue 4 (5th February 2019) Authors: Vlasakakis, Georgios; Napolitano, Antonella; Barnard, Ruth; Brown, Kim; Bullman, Jonathan; Inman, David; Keymeulen, Bart; Lanham, David; Leirens, Quentin; MacDonald, Alexander; Mezzalana, Enrica; Page, Kevin; Patel, Minesh; Savage, Caroline O.; Zamuner, Stefano; van Maurik, Andre Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 4(2019) Page Start: 704 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 3 (March 2017) Authors: Meininger, Vincent; Genge, Angela; van den Berg, Leonard H; Robberecht, Wim; Ludolph, Albert; Chio, Adriano; Kim, Seung H; Leigh, P Nigel; Kiernan, Matthew C; Shefner, Jeremy M; Desnuelle, Claude; Morrison, Karen E; Petri, Susanne; Boswell, Diane; Temple, Jane; Mohindra, Rajat; Davies, Matt; Bull... Journal: Lancet neurology Issue: Volume 16:Issue 3(2017:Mar.) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy. Issue 4 (April 2015) Authors: Ostenfeld, Thor; Krishen, Alok; Lai, Robert Y.; Bullman, Jonathan; Green, Joanne; Anand, Praveen; Scholz, Joachim; Kelly, Madeline Journal: Clinical journal of pain Issue: Volume 31:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy. Issue 4 (April 2015) Authors: Ostenfeld, Thor; Krishen, Alok; Lai, Robert Y.; Bullman, Jonathan; Green, Joanne; Anand, Praveen; Scholz, Joachim; Kelly, Madeline Journal: Clinical journal of pain Issue: Volume 31:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗